ARIELLE FLEISCHER: Open Payments
NPI 1447033352 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$978 in 38 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $617 · 2025 $978
Food & beverage: $978
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $233 |
| GENZYME CORPORATION | 3 | $212 |
| PFIZER INC. | 7 | $178 |
| Phathom Pharmaceuticals, Inc. | 1 | $121 |
| Regeneron Healthcare Solutions, Inc. | 3 | $56 |
| Aimmune Therapeutics, Inc. | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Ferring Pharmaceuticals Inc. | 1 | $22 |
| Ardelyx, Inc. | 1 | $21 |
| Madrigal Pharmaceuticals | 1 | $19 |
Products named: DUPIXENT, VELSIPITY, VOQUEZNA, RINVOQ, CREON, VOWST, XELJANZ, REBYOTA.
Industry payments across NJ — which companies pay providers there.
